<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00805298</url>
  </required_header>
  <id_info>
    <org_study_id>2008-000866-22</org_study_id>
    <secondary_id>01.01.08Jen</secondary_id>
    <nct_id>NCT00805298</nct_id>
  </id_info>
  <brief_title>Assessment of the Operative Course in Connection With Removal of Lower Third Molars</brief_title>
  <official_title>Assessment of the Operative Course in Connection With Removal of Lower Third Molars With Particular Consideration to the Occurence of Pain and Swelling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tandlaegeforeningen, Calcin fonden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare postoperative complications after removal of lower third
      molars using two different types of anaesthetics and two different treatments against
      swelling and inflammation (methylprednisolone and placebo). The hypothesis is that a
      combination of a long-duration anaesthetic combined methylprednisolone will result in
      significantly less postoperative pain and inflammation.

      Patients will have both lower third molars removed on two separate occasions. Each patient is
      randomly assigned to receive one type of local anaesthetic the first time and the other type
      the second time. Furthermore patients are randomised to receive either methylprednisolone or
      placebo the first time and the opposite treatment the second time.

      During the week after surgery patients fill out a questionnaire with questions about level of
      pain and swelling at different times as well as the patients' perception of other
      postoperative complications. The patient is examined by a dentist on the 2nd and 7th day
      after surgery, where postoperative complications are recorded and thermographic images of the
      patient's face are taken to assess the degree of inflammation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: After removal of lower third molars complications can occur, including pain,
      swelling, infection and sensory disturbances. As pain intensity has been shown to be worst
      during the first 4-8 hours post surgery, it might be relevant to use a local anaesthetic with
      long duration, e.g. bupivacaine, instead of the traditionally used lidocaine. Several studies
      have focussed on the effect of non-steroid anti-inflammatory drugs (such as glucocorticoids,
      e.g. methylprednisolone) to reduce postoperative swelling. However, no studies comparing the
      effect of bupivacaine combined with methylprednisolone and lidocaine combined with
      methylprednisolone have been conducted.

      Aim: To compare postoperative complications after removal of lower third molars using 1)
      lidocaine, 2) lidocaine combined with methylprednisolone, 3) bupivacaine and 4) bupivacaine
      combined with methylprednisolone.

      Methods: The study compares type end extension of postoperative complications after removal
      of lower third molars using four different combinations of local anaesthetics and
      anti-inflammatory treatment. The study is conducted as a double blinded, split mouth
      crossover trial, where each patient has both lower third molars removed at two different
      occasions.

      Patients are randomised to receive one type of local anaesthetic the first time and the other
      type the second time. Furthermore patients are randomised to receive either
      methylprednisolone or placebo the first time and the opposite treatment the second time.

      An objective assessment of postoperative swelling and inflammation is made by means of
      thermographic imaging of the operated side compared to the opposite side after the operation
      and at 2 and 7 days post surgery.

      Each patient fills out a questionnaire, where the patients' perception of pain, swelling and
      other complications is registered. Furthermore, complications are recorded objectively by a
      dentist at the 2- and 7-day post-surgery visits
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>within the first week after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative inflammation</measure>
    <time_frame>within the first week after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>use of analgesics</measure>
    <time_frame>within one week after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>absence from work</measure>
    <time_frame>within one week after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>trismus</measure>
    <time_frame>within one week after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alveolitis (dry socket)</measure>
    <time_frame>within one week after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sensory disturbance</measure>
    <time_frame>within one week after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylprednisolone</intervention_name>
    <description>32 mg before surgery, 16 mg twice daily the day after surgery</description>
    <arm_group_label>methylprednisolone</arm_group_label>
    <other_name>medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>two tablets before surgery, one tablet twice daily on the day after surgery</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>xyloplyin adrenalin</intervention_name>
    <description>lidocaine local anaesthetic lidocaine 20 mg/ml, adrenalin 12,5 µg/ml maximum dosage 10 ml.</description>
    <arm_group_label>lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>marcain adrenalin</intervention_name>
    <description>bupivacaine local anaesthetic bupivacaine 5 mg /ml, adrenaline 5 µg/ml maximum dosage 10 ml</description>
    <arm_group_label>bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 18 years

          -  two impacted or semi-impacted lower third molars with indication for removal

          -  signed informed consent

        Exclusion Criteria:

          -  allergy to study drugs or ingredients

          -  need for sedation

          -  pregnancy

          -  systemic disease besides asthma/hay fever
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer H Christensen, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Dentistry, Aarhus University</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Beirne OR, Hollander B. The effect of methylprednisolone on pain, trismus, and swelling after removal of third molars. Oral Surg Oral Med Oral Pathol. 1986 Feb;61(2):134-8.</citation>
    <PMID>3457335</PMID>
  </reference>
  <reference>
    <citation>Bouloux GF, Punnia-Moorthy A. Bupivacaine versus lidocaine for third molar surgery: a double-blind, randomized, crossover study. J Oral Maxillofac Surg. 1999 May;57(5):510-4; discussion 515.</citation>
    <PMID>10319823</PMID>
  </reference>
  <reference>
    <citation>Bruce RA, Frederickson GC, Small GS. Age of patients and morbidity associated with mandibular third molar surgery. J Am Dent Assoc. 1980 Aug;101(2):240-5.</citation>
    <PMID>6931159</PMID>
  </reference>
  <reference>
    <citation>Bystedt H, Nordenram A. Effect of methylprednisolone on complications after removal of impacted mandibular third molars. Swed Dent J. 1985;9(2):65-9.</citation>
    <PMID>3859943</PMID>
  </reference>
  <reference>
    <citation>Campbell WI, Kendrick RW, Ramsay-Baggs P, McCaughey W. The effect of pre-operative administration of bupivacaine compared with its postoperative use. Anaesthesia. 1997 Dec;52(12):1212-6.</citation>
    <PMID>9485979</PMID>
  </reference>
  <reference>
    <citation>Chiapasco M, De Cicco L, Marrone G. Side effects and complications associated with third molar surgery. Oral Surg Oral Med Oral Pathol. 1993 Oct;76(4):412-20.</citation>
    <PMID>8233418</PMID>
  </reference>
  <reference>
    <citation>de Boer MP, Raghoebar GM, Stegenga B, Schoen PJ, Boering G. Complications after mandibular third molar extraction. Quintessence Int. 1995 Nov;26(11):779-84.</citation>
    <PMID>8628837</PMID>
  </reference>
  <reference>
    <citation>Esen E, Taşar F, Akhan O. Determination of the anti-inflammatory effects of methylprednisolone on the sequelae of third molar surgery. J Oral Maxillofac Surg. 1999 Oct;57(10):1201-6; discussion 1206-8.</citation>
    <PMID>10513866</PMID>
  </reference>
  <reference>
    <citation>Holland CS. The influence of methylprednisolone on post-operative swelling following oral surgery. Br J Oral Maxillofac Surg. 1987 Aug;25(4):293-9.</citation>
    <PMID>3304412</PMID>
  </reference>
  <reference>
    <citation>Leone M, Richard O, Antonini F, Rousseau S, Chabaane W, Guyot L, Martin C. Comparison of methylprednisolone and ketoprofen after multiple third molar extraction: a randomized controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jan;103(1):e7-9. Epub 2006 Oct 6.</citation>
    <PMID>17178485</PMID>
  </reference>
  <reference>
    <citation>Marković AB, Todorović L. Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Nov;102(5):e4-8. Epub 2006 Aug 10.</citation>
    <PMID>17052624</PMID>
  </reference>
  <reference>
    <citation>Mellor DJ, Mellor AH, McAteer EM. Local anaesthetic infiltration for surgical exodontia of third molar teeth: a double-blind study comparing bupivacaine infiltration with i.v. ketorolac. Br J Anaesth. 1998 Oct;81(4):511-4.</citation>
    <PMID>9924222</PMID>
  </reference>
  <reference>
    <citation>Mettes TG, Nienhuijs ME, van der Sanden WJ, Verdonschot EH, Plasschaert AJ. Interventions for treating asymptomatic impacted wisdom teeth in adolescents and adults. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003879. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD003879.</citation>
    <PMID>15846686</PMID>
  </reference>
  <reference>
    <citation>Micó-Llorens JM, Satorres-Nieto M, Gargallo-Albiol J, Arnabat-Domínguez J, Berini-Aytés L, Gay-Escoda C. Efficacy of methylprednisolone in controlling complications after impacted lower third molar surgical extraction. Eur J Clin Pharmacol. 2006 Sep;62(9):693-8. Epub 2006 Aug 11.</citation>
    <PMID>16902792</PMID>
  </reference>
  <reference>
    <citation>Moore PA. Bupivacaine: a long-lasting local anesthetic for dentistry. Oral Surg Oral Med Oral Pathol. 1984 Oct;58(4):369-74. Review.</citation>
    <PMID>6387571</PMID>
  </reference>
  <reference>
    <citation>Nayyar MS, Yates C. Bupivacaine as pre-emptive analgesia in third molar surgery: Randomised controlled trial. Br J Oral Maxillofac Surg. 2006 Dec;44(6):501-3. Epub 2006 Feb 2.</citation>
    <PMID>16457912</PMID>
  </reference>
  <reference>
    <citation>Neal JA, Welch TB, Halliday RW. Analysis of the analgesic efficacy and cost-effective use of long-acting local anesthetics in outpatient third molar surgery. Oral Surg Oral Med Oral Pathol. 1993 Mar;75(3):283-5.</citation>
    <PMID>8469535</PMID>
  </reference>
  <reference>
    <citation>Osborn TP, Frederickson G Jr, Small IA, Torgerson TS. A prospective study of complications related to mandibular third molar surgery. J Oral Maxillofac Surg. 1985 Oct;43(10):767-9.</citation>
    <PMID>2995624</PMID>
  </reference>
  <reference>
    <citation>Renton T, Hankins M, Sproate C, McGurk M. A randomised controlled clinical trial to compare the incidence of injury to the inferior alveolar nerve as a result of coronectomy and removal of mandibular third molars. Br J Oral Maxillofac Surg. 2005 Feb;43(1):7-12.</citation>
    <PMID>15620767</PMID>
  </reference>
  <reference>
    <citation>Schultze-Mosgau S, Schmelzeisen R, Frölich JC, Schmele H. Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg. 1995 Jan;53(1):2-7; discussion 7-8.</citation>
    <PMID>7799116</PMID>
  </reference>
  <reference>
    <citation>Sisk AL, Hammer WB, Shelton DW, Joy ED Jr. Complications following removal of impacted third molars: the role of the experience of the surgeon. J Oral Maxillofac Surg. 1986 Nov;44(11):855-9.</citation>
    <PMID>3464711</PMID>
  </reference>
  <reference>
    <citation>Skjelbred P, Løkken P. Effects of naloxone on post-operative pain and steroid-induced analgesia. Br J Clin Pharmacol. 1983 Feb;15(2):221-6.</citation>
    <PMID>6849755</PMID>
  </reference>
  <reference>
    <citation>Song F, O'Meara S, Wilson P, Golder S, Kleijnen J. The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. Health Technol Assess. 2000;4(15):1-55. Review.</citation>
    <PMID>10932022</PMID>
  </reference>
  <reference>
    <citation>UStün Y, Erdogan O, Esen E, Karsli ED. Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Nov;96(5):535-9.</citation>
    <PMID>14600686</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2008</study_first_submitted>
  <study_first_submitted_qc>December 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2008</study_first_posted>
  <last_update_submitted>October 23, 2012</last_update_submitted>
  <last_update_submitted_qc>October 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>third molar</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>thermography</keyword>
  <keyword>postoperative inflammation</keyword>
  <keyword>methylprednisolone</keyword>
  <keyword>local anaesthetic</keyword>
  <keyword>postoperative pain after removal of lower third molars</keyword>
  <keyword>inflammation after removal of lower third molars</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

